BRIEF-Pharming Group enters into collaboration with Clinigen Group
May 18 (Reuters) - Pharming Group NV :
* Enters into an international global access collaboration with Clinigen Group for HAEi
* HAEi GAP program will provide access to RUCONEST (Conestat Alfa) to eligible patients with hereditary angioedema (HAE)
Source text for Eikon: Further company coverage: (Gdynia Newsroom)
© Thomson Reuters 2017 All rights reserved.